Cargando…

A guide to the extrapyramidal side-effects of antipsychotic drugs /

Antipsychotic drugs have revolutionised the management of major psychiatric disorders and the outcomes of those who suffer from them. They are, however, possessed of a range of adverse effects, amongst the most frequent and distressing of which are those resulting in disturbance of voluntary motor f...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Owens, D. G. Cunningham (David Griffith Cunningham), 1949-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cambridge ; New York : Cambridge University Press, 1999.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBSCO_ocm56191173
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu|||unuuu
008 040813s1999 enka ob 001 0 eng d
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d YDXCP  |d OCLCG  |d OCLCQ  |d OCLCO  |d VVN  |d OQP  |d CO3  |d E7B  |d EBLCP  |d AU@  |d IDEBK  |d OCLCQ  |d OCLCF  |d OCLCQ  |d DKDLA  |d OCLCQ  |d NLGGC  |d OCLCQ  |d AUD  |d OCLCQ  |d AZK  |d COCUF  |d AGLDB  |d TOA  |d MOR  |d OCLCO  |d PIFBR  |d OCLCQ  |d OCLCA  |d U3W  |d OCLCA  |d UAB  |d STF  |d VNS  |d WRM  |d OCLCO  |d OCLCQ  |d VTS  |d OCLCO  |d NRAMU  |d VT2  |d OCLCQ  |d WYU  |d OCLCA  |d REC  |d OCLCO  |d M8D  |d OCLCO  |d UX1  |d OCLCQ  |d K6U  |d OCLCA  |d INARC  |d UKCRE  |d TUHNV  |d BUB  |d LUN  |d QGK  |d UKAHL  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 49848324  |a 56732875  |a 271787923  |a 559352563  |a 722743936  |a 776971032  |a 814262269  |a 819627631  |a 824532730  |a 888506858  |a 961660113  |a 962573864  |a 976517940  |a 988495971  |a 992018435  |a 1035708631  |a 1037752371  |a 1038701745  |a 1045441367  |a 1055370505  |a 1064026278  |a 1153553340  |a 1167573820  |a 1228552228  |a 1241951810  |a 1243612382  |a 1252730092  |a 1259276999 
020 |a 0511005970  |q (electronic bk.) 
020 |a 9780511005978  |q (electronic bk.) 
020 |a 0511036051  |q (electronic bk. ;  |q Adobe Reader) 
020 |a 9780511036057  |q (electronic bk. ;  |q Adobe Reader) 
020 |a 0511117167  |q (electronic bk.) 
020 |a 9780511117169  |q (electronic bk.) 
020 |a 9780521633536 
020 |a 0521633532 
020 |a 9780511544163  |q (ebook) 
020 |a 0511544162 
020 |a 1107111153 
020 |a 9781107111158 
020 |a 1280158883 
020 |a 9781280158889 
020 |a 9786610158881 
020 |a 6610158886 
020 |a 0511149085 
020 |a 9780511149085 
020 |a 0511302924 
020 |a 9780511302923 
020 |z 0521633532  |q (pbk.) 
029 1 |a AU@  |b 000042831958 
029 1 |a AU@  |b 000051368750 
029 1 |a AU@  |b 000053230164 
029 1 |a AU@  |b 000062510618 
029 1 |a DEBBG  |b BV043095966 
029 1 |a DEBSZ  |b 422483559 
029 1 |a GBVCP  |b 801173507 
029 1 |a NZ1  |b 11915940 
035 |a (OCoLC)56191173  |z (OCoLC)49848324  |z (OCoLC)56732875  |z (OCoLC)271787923  |z (OCoLC)559352563  |z (OCoLC)722743936  |z (OCoLC)776971032  |z (OCoLC)814262269  |z (OCoLC)819627631  |z (OCoLC)824532730  |z (OCoLC)888506858  |z (OCoLC)961660113  |z (OCoLC)962573864  |z (OCoLC)976517940  |z (OCoLC)988495971  |z (OCoLC)992018435  |z (OCoLC)1035708631  |z (OCoLC)1037752371  |z (OCoLC)1038701745  |z (OCoLC)1045441367  |z (OCoLC)1055370505  |z (OCoLC)1064026278  |z (OCoLC)1153553340  |z (OCoLC)1167573820  |z (OCoLC)1228552228  |z (OCoLC)1241951810  |z (OCoLC)1243612382  |z (OCoLC)1252730092  |z (OCoLC)1259276999 
050 4 |a RC376.5  |b .O95 1999eb 
060 4 |a WL 307 O97g 1998 
072 7 |a HEA  |x 039140  |2 bisacsh 
072 7 |a MED  |x 056000  |2 bisacsh 
082 0 4 |a 616.8/3  |2 22 
049 |a UAMI 
100 1 |a Owens, D. G. Cunningham  |q (David Griffith Cunningham),  |d 1949- 
245 1 2 |a A guide to the extrapyramidal side-effects of antipsychotic drugs /  |c D.G. Cunningham Owens. 
260 |a Cambridge ;  |a New York :  |b Cambridge University Press,  |c 1999. 
300 |a 1 online resource (x, 351 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
504 |a Includes bibliographical references (pages 320-345) and index. 
588 0 |a Print version record. 
520 |a Antipsychotic drugs have revolutionised the management of major psychiatric disorders and the outcomes of those who suffer from them. They are, however, possessed of a range of adverse effects, amongst the most frequent and distressing of which are those resulting in disturbance of voluntary motor function. Extrapyramidal side effects - or E.P.S. - are still poorly recognised and not infrequently misattributed. Despite a vast research literature, there have been few attempts to bring together both the descriptive clinical elements of these disorders and major research conclusions pertinent to routine practice. This very readable and well illustrated 1999 book seeks to rectify this in the hope of increasing clinicians' awareness of the issues and acknowledgement of their impact. This is a task made more rather than less urgent with the emergence of drugs of lower liability but which may promote subtler abnormality than standard compounds. 
505 0 |a Preface -- 1 The background -- Introduction -- The Golden Age -- The chlorpromazine story -- In the wake of chlorpromazine -- Practice, theory and names -- 'Typicality' versus 'atypicality' -- 2 Some preliminaries -- The need for vigilance -- The classification of drug-related movement disorders -- The villains of the piece -- A small caveat -- 3 Acute dystonias -- Introduction -- The concept of dystonia -- Clinical features -- Diagnosis -- Epidemiology -- Predisposing factors -- Onset, course and outcome -- Treatment -- Pathophysiology. 
505 8 |a Addendum: acute dystonias and oculogyric crises -- 4 Parkinsonism -- Introduction -- Terminology -- Clinical features -- Diagnosis -- Epidemiology -- Predisposing factors -- Onset, course and outcome -- Treatment -- Pathophysiology -- 5 Akathisia -- Introduction -- Terminology and concepts -- Clinical features -- Modifying factors -- Diagnosis -- Epidemiology -- Predisposing factors -- Onset, course and outcome -- Treatment -- Pathophysiology -- 6 Tardive dyskinesia -- Introduction -- The concept of tardive dyskinesia -- Clinical features -- Operationalised criteria for tardive dyskinesia. 
505 8 |a Modifying factors -- Diagnosis -- Epidemiology -- Predisposing factors -- Onset, course and outcome -- Treatment -- Pathophysiology -- Clinical subtypes -- 7 Tardive and chronic dystonia -- Introduction -- Definition and classification of chronic dystonia -- Clinical features -- Characteristics of dystonia -- Diagnosis -- Epidemiology -- Predisposing factors -- Onset, course and outcome -- Treatment -- 8 Involuntary movements and schizophrenia: a limitation to the concept of tardive dyskinesia? -- Introduction -- The descriptive evidence -- The Shenley Study. 
505 8 |a The limitations of the concept of tardive dyskinesia -- 9 Special populations -- Children and adolescents -- Learning disability -- The elderly -- Acquired immune deficiency syndrome -- 10 The clinical examination -- Introduction -- Preliminaries -- The standardised examination -- 11 An overview of some standardised recording instruments -- Introduction -- The origins of rating scales for movement disorders -- Principles involved in rating scales -- Standardised rating scales for Parkinson's disease -- Standardised rating scales for drug-related parkinsonism. 
505 8 |a Standardised rating scales for tardive dyskinesia -- Standardised rating scales for akathisia -- Standardised rating scales for dystonia -- Combined rating scales -- Learning disability -- Some general issues -- The choice of scale -- 12 Some medicolegal and quality-of-care issues -- Introduction -- 'Informing' consent -- The medicolegal dimension -- New drugs for old? -- Some practical suggestions -- References -- Index. 
546 |a English. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Extrapyramidal disorders. 
650 0 |a Antipsychotic drugs  |x Side effects. 
650 1 2 |a Basal Ganglia Diseases  |x diagnosis 
650 1 2 |a Basal Ganglia Diseases  |x drug therapy 
650 2 2 |a Antipsychotic Agents  |x adverse effects 
650 2 2 |a Extrapyramidal Tracts  |x drug effects 
650 6 |a Syndrome extrapyramidal. 
650 6 |a Neuroleptiques  |x Effets secondaires. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Alzheimer's & Dementia.  |2 bisacsh 
650 7 |a MEDICAL  |x Neurology.  |2 bisacsh 
650 7 |a Antipsychotic drugs  |x Side effects  |2 fast 
650 7 |a Extrapyramidal disorders  |2 fast 
776 0 8 |i Print version:  |a Owens, D.G. Cunningham (David Griffith Cunningham), 1949-  |t Guide to the extrapyramidal side-effects of antipsychotic drugs.  |d Cambridge ; New York : Cambridge University Press, 1999  |z 0521633532  |w (DLC) 98007142  |w (OCoLC)38937477 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=55793  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH13422992 
938 |a ebrary  |b EBRY  |n ebr2000719 
938 |a EBSCOhost  |b EBSC  |n 55793 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 15888 
938 |a Internet Archive  |b INAR  |n guidetoextrapyra0000owen 
938 |a Internet Archive  |b INAR  |n guidetoextrapyra0004owen_cba157 
938 |a YBP Library Services  |b YANK  |n 2299819 
938 |a YBP Library Services  |b YANK  |n 2617378 
938 |a YBP Library Services  |b YANK  |n 2826039 
938 |a YBP Library Services  |b YANK  |n 3275989 
994 |a 92  |b IZTAP